Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort.

Détails

Ressource 1Télécharger: 37892775_BIB_1861932F854E.pdf (2407.47 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_1861932F854E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort.
Périodique
Journal of clinical medicine
Auteur⸱e⸱s
Mangold V., Boesing M., Berset C., Bridevaux P.O., Geiser T., Joos Zellweger L., Kohler M., Lüthi-Corridori G., Maier S., Miedinger D., Thurnheer R., von Garnier C., Leuppi J.D.
ISSN
2077-0383 (Print)
ISSN-L
2077-0383
Statut éditorial
Publié
Date de publication
20/10/2023
Peer-reviewed
Oui
Volume
12
Numéro
20
Pages
6636
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
(1) Introduction: Chronic obstructive pulmonary disease (COPD) and its associated morbidity and mortality are a global burden on both affected patients and healthcare systems. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) issues guidelines with the aim of improving COPD management. Previous studies reported significant variability in adherence to these recommendations. The objective of this study was to evaluate Swiss primary practitioners' adherence to the GOLD guidelines for the pharmacological treatment of stable COPD. (2) Methods: We studied patients who were included in the Swiss COPD cohort study, an ongoing prospective study in a primary care setting, between 2015 and 2022. The key inclusion criteria are age ≥ 40 years, FEV1/FVC ratio < 70%, and a smoking history of at least 20 pack-years. Adherence to the GOLD guidelines was assessed per visit and over time. (3) Results: The data of 225 COPD patients (mean age 67 ± 9 years, 64% male) and their respective 1163 visits were analyzed. In 65% of visits (726/1121), treatment was prescribed according to the GOLD guidelines. Non-adherence was most common in GOLD groups A and B (64% and 33%) and mainly consisted of over-treatment (two long-acting bronchodilators in group A (98/195, 50%) and ICS in groups A (21/195, 11%) and B (198/808, 25%)). In group D, the prescriptions conformed with the guidelines in 99% of cases (109/108). Guideline adherence was associated with high symptom load (COPD Assessment Test) (OR 1.04, p = 0.002), high number of exacerbations (OR = 2.07, p < 0.001), asthma overlap (OR 3.36, p = 0.049), and diabetes mellitus (OR 2.82, p = 0.045). (4) Conclusion: These results confirm a conflict between the GOLD recommendations and primary practice, mainly concerning over-treatment in GOLD groups A and B. Patients with high symptom load, high exacerbation risk, asthma overlap, and diabetes mellitus are more likely to be treated in conformity with the guidelines. Further research is needed to uncover the reasons for the discrepancies and to design strategies for improvement.
Mots-clé
COPD, GOLD guidelines, adherence, bronchodilators, inhaled corticosteroids, primary care
Pubmed
Web of science
Open Access
Oui
Création de la notice
06/11/2023 14:17
Dernière modification de la notice
25/01/2024 8:31
Données d'usage